Ahmed Bakry

StoneView

StoneView, a subsidiary of FourStone Partners, is composed of two separate companies, StoneView Network Services and StoneView Lab Services. StoneView Network Services offers an innovative national Workers' Compensation PPO network that is customized to meet the highly unique needs of customers. Key benefits include national/regional network strategy developed on a per state basis for best in class savings and penetration results, direct provider contracting and seamless integration with client software. This is accomplished by selecting only the highest quality providers/partners who accept and understand the unique design of our model and the needs of our clients. The success of the StoneView network is based on savings, quality, and accessibility. StoneView Lab Services (formerly Insight Labs) offers clinically actionable pharmacogenomic testing to determine how individuals will respond to medications before they are prescribed. This is an evolving area of personalized medicine that defies the "one size fits all" approach while improving care, reducing polypharmacy and lowering healthcare costs. More than 90% of the US population has at least one genetic variation that affects response to medication (Source: National Center for Biotechnology Information). The same medication dose may be effective for one person, have no effect for another and may cause harm to a third person. These variants can render whole classes of drugs ineffective or even dangerous. Some common areas of medicine that benefit from pharmacogenomic testing include pain management, psychiatry, anesthesiology, anticoagulation, cardiology, oncology and geriatrics. StoneView's pharmacogenomic test is a tool that enables providers to prescribe the right medication at the right dose for the right patient. The test also identifies medications that may be harmful and should be avoided.